Imatinib Completed Phase 2 Trials for Chronic Eosinophilic Leukemia (CEL) / Chronic Idiopathic Hypereosinophilia / Hypereosinophilic Syndromes Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00787384Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes